About Index Trending news
Analyze
Top 50 Pricing
Genocea Biosciences

Genocea Biosciences

Work at Genocea Biosciences? Add yourself to this profile

Genocea Biosciences

Harnessing T cells to save and improve millions of lives

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Post-IPO equity
$51,700,000
Post-IPO debt
$27,000,000
Employees

Team size

50+
Locations
HQ
Xconomy

Genocea Touts Early Look at Placebo-Controlled Herpes Vaccine Study

The Motley Fool

Why It's Been a Wild Few Days for Genocea Biosciences Inc.

Health Stock markets
Xconomy

Genocea Ditches Pneumococcus Vaccine After Phase 2 Flop, Shares Fall